NFGH
TSVT

Nan Fung Group Holdings’s 2seventy bio TSVT Stock Holding History

Nan Fung Group Holdings’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,273
Closed -$586K – 44
2022
Q3 		$586K Hold
40,273
– – 0.37% 24
2022
Q2 		$532K Hold
40,273
– – 0.37% 25
2022
Q1 		$687K Buy
+40,273
New +$683K 0.33% 28

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Nan Fung Group Holdings's TSVT Position: Q4 2022 in Review

Nan Fung Group Holdings sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 40,273 shares — an estimated $586K sold.

Nan Fung Group Holdings first reported a position in TSVT in Q1 2022 and held it in 3 quarters. The position peaked at $687K in Q1 2022. 142 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

  • Nan Fung Group Holdings reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 40,273 2seventy bio shares in Q4 2022, an estimated $586K.
  • Nan Fung Group Holdings first reported a position in 2seventy bio in Q1 2022 and held it in 3 quarters.
  • Nan Fung Group Holdings's 2seventy bio position peaked at $687K in Q1 2022.
  • 142 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on Nan Fung Group Holdings's 13F filing for Q4 2022, filed 13 Feb 2023.